Glenmark Pharmaceuticals

Glenmark receives FDA approval for Moexipril Hydrochloride tablets

18 Mar 2010

Glenmark gets nod to market skin cream in US

16 Nov 2009

Glenmark, Forest drug trial for COPD fails

19 Aug 2009

Glenmark faces GSK patent challenge in US over malaria drug

18 Aug 2009

Glenmark to withdraw painkiller from US market

02 Apr 2009

Glenmark launches `Azathioprine' tablets in US

20 Nov 2008

Glenmark gets ANDA approval from US FDA for generic betamethasone corticosteroid

25 Sep 2008

Glenmark gets USFDA approval for anti-hypertensive, Trandolapril

20 Jun 2008

Glenmark gets nod for marketing two drugs in US

30 May 2008

Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500

10 Apr 2008

Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline

17 Mar 2008

Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat

06 Feb 2008

US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant

28 Jan 2008

WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug

14 Jan 2008

Glenmark Pharma to spin off generics unit, list new unit next year

17 Nov 2007

Glenmark signs up marketing deal with MyerZall Labs

By | 27 Oct 2007

Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa

By | 25 Oct 2007

Glenmark Pharmaceuticals to market epilepsy drug oxcarbazepine in the US

By | 10 Oct 2007

Glenmark receives US FDA approval for cardiac and NSAIDs generics

16 May 2007

Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets

28 Mar 2007

Glenmark in funded research agreement with Swiss firm Dyax

12 Mar 2007

Glenmark develops API for Napo''s phase III diarrhoea drug trials by US

17 Nov 2006

Glenmark, is India''s first pharma company to implement ''structured product labeling''

31 Mar 2006

Glenmark Pharmaceuticals Clinical Research unit in India receives ANVISA approval

08 Feb 2006

Glenmark Pharmaceuticals targets GPs

By Our Corporate Bureau | 10 Oct 2005